Luca Lanino

16PUBLICATIONS
196CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markersMedical mycologyGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Apr 11, 2026
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia.

Saubia Fathima, Lior Rokach, Muhammad Yousuf

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

Pageof 3

Frequent Collaborators

13 joint publications

Matteo Giovanni Della Porta

10 joint publications

Valeria Santini

8 joint publications

Maria Diez-Campelo

8 joint publications

Rami S Komrokji